302550 Stock Chart & Stats
₩2650.00
-₩60.00(-2.21%)
―
--
Day’s Range― - ―
52-Week Range₩2,300.00 - ₩4,595.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)66.51K
Market Cap
₩83.76B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)68.9
Beta0.22
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding30,907,150
10 Day Avg. Volume50,995
30 Day Avg. Volume66,513
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)₩10.00T>
302550 FAQ
What was REMED Co., Ltd.’s price range in the past 12 months?
REMED Co., Ltd. lowest stock price was ₩2300.00 and its highest was ₩4595.00 in the past 12 months.
What is REMED Co., Ltd.’s market cap?
REMED Co., Ltd.’s market cap is ₩83.76B.
When is REMED Co., Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were REMED Co., Ltd.’s earnings last quarter?
REMED Co., Ltd. released its earnings results on May 14, 2026. The company reported ₩36.22 earnings per share for the quarter, beating the consensus estimate of N/A by ₩36.22.
Is REMED Co., Ltd. overvalued?
According to Wall Street analysts REMED Co., Ltd.’s price is currently Undervalued.
Does REMED Co., Ltd. pay dividends?
REMED Co., Ltd. does not currently pay dividends.
What is REMED Co., Ltd.’s EPS estimate?
REMED Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does REMED Co., Ltd. have?
REMED Co., Ltd. has 30,907,150 shares outstanding.
What happened to REMED Co., Ltd.’s price movement after its last earnings report?
REMED Co., Ltd. reported an EPS of ₩36.22 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 3.052%.
Which hedge fund is a major shareholder of REMED Co., Ltd.?
Currently, no hedge funds are holding shares in KR:302550
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Icure Pharmaceutical Incorporation
―
Enzychem Lifesciences Corp.
―
MedPacto, Inc.
―
Vaxcell-Bio Therapeutics
―
WITHUS PHARMACEUTICAL Co., Ltd.
―